Follow
Georgia Kontogianni
Georgia Kontogianni
BRFAA/ NHRF/ UniPi
Verified email at eie.gr
Title
Cited by
Cited by
Year
Drosophila oogenesis as a bio-marker responding to EMF sources
LH Margaritis, AK Manta, KD Kokkaliaris, D Schiza, K Alimisis, G Barkas, ...
Electromagnetic Biology and Medicine 33 (3), 165-189, 2014
562014
Novel pyrazolopyridine derivatives as potential angiogenesis inhibitors: Synthesis, biological evaluation and transcriptome-based mechanistic analysis
M Michailidou, V Giannouli, V Kotsikoris, O Papadodima, G Kontogianni, ...
European Journal of Medicinal Chemistry 121, 143-157, 2016
292016
BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis
K Koumaki, G Kontogianni, V Kosmidou, F Pahitsa, E Kritsi, M Zervou, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (4), 166061, 2021
182021
Dissecting the mutational landscape of cutaneous melanoma: an Omic analysis based on patients from Greece
G Kontogianni, G Piroti, I Maglogiannis, A Chatziioannou, O Papadodima
Cancers 10 (4), 96, 2018
142018
Hepatic gene expression variations in response to high-fat diet-induced impaired glucose tolerance using RNAseq analysis in collaborative cross mouse population
HJ Abu-Toamih Atamni, G Kontogianni, I Binenbaum, R Mott, ...
Mammalian Genome 30, 260-275, 2019
132019
Container-aided integrative QTL and RNA-seq analysis of Collaborative Cross mice supports distinct sex-oriented molecular modes of response in obesity
I Binenbaum, HAT Atamni, G Fotakis, G Kontogianni, T Koutsandreas, ...
BMC genomics 21, 1-13, 2020
112020
Genomics of cutaneous melanoma: focus on next-generation sequencing approaches and bioinformatics
O Papadodima, G Kontogianni, G Piroti, I Maglogiannis, A Chatziioannou
J. Transl. Genet. Genom 3 (7), 2019
52019
Redesigning EHRs and clinical decision support systems for the precision medicine era
I Maglogiannis, T Goudas, A Billiris, H Karanikas, I Valavanis, ...
Proceedings of the 16th International Conference on Engineering Applications …, 2015
52015
An integrated platform for skin cancer heterogenous and multilayered data management
I Maglogiannis, G Kontogianni, O Papadodima, H Karanikas, A Billiris, ...
Journal of Medical Systems 45 (1), 10, 2021
42021
Exploring the Molecular Determinants of Tumor-Stroma Interaction in Non-Small Cell Lung Cancer Through the Utilization of RNA-Seq Data from Lung Biopsies
G Kontogianni, O Papadodima, A Mitrakas, I Maglogiannis, ...
XIV Mediterranean Conference on Medical and Biological Engineering and …, 2016
42016
Integrative Bioinformatic Analysis of a Greek Epidemiological Cohort Provides Insight into the Pathogenesis of Primary Cutaneous Melanoma
G Kontogianni, O Papadodima, I Maglogiannis, K Frangia-Tsivou, ...
Artificial Intelligence Applications and Innovations: 12th IFIP WG 12.5 …, 2016
32016
A review on state-of-the-art computer-based approaches for the early recognition of malignant melanoma
G Kontogianni, I Maglogiannis
Advanced Computational Intelligence in Healthcare-7: Biomedical Informatics …, 2020
22020
An RNA-seq analysis from non-small cell lung cancer biopsies suggests an important role for aberrant alternative splicing in its pathophysiology
G Kontogianni, O Papadodima, A Mitrakas, I Maglogiannis, ...
Health and Technology 7, 133-140, 2017
22017
Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer
ACRP Charles Ricordel, L. Chaillot, E. I. Vlachavas, M. Logotheti, A ...
Scientific Reports 13 (3626 (2023)), 11, 2023
1*2023
A Comprehensive Analysis of Cutaneous Melanoma Patients in Greece Based on Multi-Omic Data
G Kontogianni, K Voutetakis, G Piroti, K Kypreou, I Stefanaki, ...
Cancers 15 (3), 815, 2023
2023
Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma
https://www.biorxiv.org/content/10.1101/2022.04.30.487775v1.article-info, 2022
2022
Development of a methodology of computational intelligence for robust composite biomarker discovery: Targeting breakthrough in the therapeutic management of melanoma
GA Kontogianni
PQDT-Global, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–17